Ally Chem Laboratories Profile
Key Indicators
- Authorised Capital ₹ 2.50 Cr
as on 05-07-2024
- Paid Up Capital ₹ 2.45 Cr
as on 05-07-2024
- Company Age 22 Year, 4 Days
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 27.48 Cr
as on 05-07-2024
- Satisfied Charges ₹ 1.04 Cr
as on 05-07-2024
- Revenue -21.81%
(FY 2023)
- Profit -102.20%
(FY 2023)
- Ebitda 20.61%
(FY 2023)
- Net Worth -4.06%
(FY 2023)
- Total Assets -3.08%
(FY 2023)
About Ally Chem Laboratories
The Company is engaged in the Chemicals And Materials Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 2.50 Cr and a paid-up capital of Rs 2.45 Cr.
The company currently has active open charges totaling ₹27.48 Cr. The company has closed loans amounting to ₹1.04 Cr, as per Ministry of Corporate Affairs (MCA) records.
Anil Jha and Kushal Singh serve as directors at the Company.
- CIN/LLPIN
U24231CH2002PTC025656
- Company No.
025656
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
20 Dec 2002
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Chandigarh
Industry
Company Details
- Location
Chandigarh, Chandigarh, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Ally Chem Laboratories?
Board Members(2)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Anil Jha | Additional Director | 14-Mar-2024 | Current |
Kushal Singh | Director | 20-Dec-2002 | Current |
Financial Performance of Ally Chem Laboratories.
Ally Chem Laboratories Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 21.81% decrease. The company also saw a substantial fall in profitability, with a 102.2% decrease in profit. The company's net worth dipped by a decrease of 4.06%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue |
| ||||||
Revenue from Operations |
| ||||||
Total Assets |
| ||||||
Profit or Loss |
| ||||||
Net Worth |
| ||||||
EBITDA |
|
What is the Ownership and Shareholding Structure of Ally Chem Laboratories?
In 2023, Ally Chem Laboratories had a promoter holding of 93.93% and a public holding of 6.07%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
Lender | Amount | Status |
---|---|---|
Pkf Finance Limited Creation Date: 31 Mar 2014 | ₹3.20 M | Open |
Punjab National Bank Creation Date: 13 Feb 2012 | ₹18.75 Cr | Open |
Punjab National Bank Creation Date: 10 Dec 2010 | ₹4.10 M | Open |
How Many Employees Work at Ally Chem Laboratories?
Ally Chem Laboratories has a workforce of 3 employees as of Apr 07, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Ally Chem Laboratories, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Ally Chem Laboratories's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.